π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Our proposal is to administer asenapine to patients who are clinically agit...
Status
Completed
Location
St. Joseph's Hospital Health Center-Comprehensive Psychiatric Emergency Program (CPEP)
Start Date
2012-04
Trial ID
NCT01400113
This is an open-label pilot study of adjunctive asenapine for the treatment...
Status
Completed
Location
Tuscaloosa VA Medical Center
Start Date
2012-06
Trial ID
NCT01587118
Treatments Being Tested
The effectiveness and efficacy of the combination of pharmacotherapy with t...
Status
Active Not Recruiting
Location
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
Start Date
2025-06-04
Trial ID
NCT07047651
Treatments Being Tested
This study is designed to evaluate efficacy and safety of HP-3070 compared ...
Status
Completed
Location
Noven Pharmaceuticals, Inc.
Start Date
2016-08
Trial ID
NCT02876900
Treatment with conventional antipsychotics such as haloperidol has little e...
Status
Completed
Location
Multiple Locations
Start Date
2005-04-21
Trial ID
NCT00212836
Treatments Being Tested
The primary objective of this trial was to characterize the long-term (up t...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00145509
This study evaluates the safety and tolerability of Asenapine in elderly pa...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00281320
Treatments Being Tested
This study is an open label, sequential-group, two site, multiple dose esca...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-18
Trial ID
NCT01206517
Treatments Being Tested
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-02-15
Trial ID
NCT00151424
Treatments Being Tested